Live
Read now

Clairyon

health AIdigital healthmedtech
StageGrant
Raised$3.11M
Founded2021
Employees6
LocationSan Diego, CA

About

Clairyon's COMPOSER-LLM early sepsis prediction model delivers a 𝟑–𝟓𝐱 𝐥𝐨𝐰𝐞𝐫 𝐟𝐚𝐥𝐬𝐞 𝐚𝐥𝐚𝐫𝐦 𝐫𝐚𝐭𝐞 than competing models—without sacrificing sensitivity. In prospective deployment, COMPOSER-LLM achieved a PPV of ~60% at ~70% sensitivity—with an effective PPV exceeding 80% when early detection of infections is included. Moreover, COMPOSER-LLM doesn’t just flag sepsis risk; it provides a 𝐟𝐮𝐥𝐥 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭𝐢𝐚𝐥 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬 𝐬𝐞𝐭, helping clinicians distinguish sepsis from mimics like cirrhosis, cardiogenic shock, and GI bleeding. And it’s not just an algorithm—it’s part of a 𝐛𝐮𝐧𝐝𝐥𝐞𝐝 𝐬𝐨𝐟𝐭𝐰𝐚𝐫𝐞 𝐬𝐮𝐢𝐭𝐞 that includes Clairyon’s SEP-1 automated abstraction engine (QUALLM) and software tools that span the entire continuum of care, quality reporting, clinical documentation improvement, and reimbursement. In a space where hype often outpaces clarity, Clairyon is building for clinical trust, operational integration, and real-world impact, backed by 𝐩𝐞𝐞𝐫-𝐫𝐞𝐯𝐢𝐞𝐰𝐞𝐝 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐞𝐯𝐢𝐝𝐞𝐧𝐜𝐞 [1-3]. Development and prospective implementation of a large language model based system for early sepsis prediction: https://www.nature.com/articles/s41746-025-01689-w Large Language Models for More Efficient Reporting of Hospital Quality Measures: https://ai.nejm.org/doi/full/10.1056/AIcs2400420 Integrating artificial intelligence into healthcare systems: more than just the algorithm: https://www.nature.com/articles/s41746-024-01066-z

Product

Value proposition
Multimodal AI-powered clinical intelligence solutions delivering real-time information to intervene when it matters most, predict adverse events, enable targeted interventions, and improve patient outcomes.

Founders

  • Aaron Boussina
  • Shamim Nemati

Products

AI Surveillance ToolGenAI Hospital Quality ReportingMultimodal clinical intelligence solutions

Key features

Real-time clinical intelligenceAdverse event predictionTargeted interventionsSepsis mortality reductionSEP-1 compliance improvementHIPAA compliantSOC 2 Type II compliant

Technologies

Artificial IntelligenceGenAImultimodal AI

Certifications

HIPAA compliantSOC 2 Type II compliant

Traction metrics

Care units monitored by prediction systems200,000+ patients helped62+ care units monitored17% reduction in sepsis mortality10% improvement in SEP-1 compliance

Investors

National Institute of Allergy and Infectious DiseasesNational Institutes of HealthNucleate

News

Browse similar startups

Related startups

Profile updated Jul 29, 2026. Sources: clairyon.com, linkedin.com

ClinAdsby ClinsightBuilt for clinics

Your clinic’s marketing team, powered by AI.

On-brand ads, SEO, and social campaigns in one place.

Generate your first clinic ad for free
Clincyby ClinsightBuilt for practices

Get more revenue from the patients you already have.

Voice and SMS that follow up until lapsed patients are back on the schedule.

Book a Clincy call
DDS RecruitPowered by ClinsightDental recruiting

Your practice’s fractional recruiting team.

Dental-only search, run end to end, with placements guaranteed for a year.

Find your next hire